Showing 20 of 48 recruiting trials for “Tumor of hematopoietic and lymphoid tissues”
Interest of Light Therapy in Hematology - The PHOTO-TREAT Study
👨⚕️ Anne ZILLIOX, MD, Institut de cancérologie Strasbourg Europe📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06058858 ↗
Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
Fasting Mimicking Diet With Chemotherapy in Patients With Leukemia
👨⚕️ Ehsan Hejazi, PhD, Beheshti University of Medical Sciences📍 2 sites📅 Started Jul 2023View details ↗
RecruitingNCT05702502 ↗
Assessing the Presence of CT-DNA in Lymphoma Associated HLH
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Enrolling by InvitationNCT05600933 ↗
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
👨⚕️ Steven A Rosenberg, M.D., National Cancer Institute (NCI)📍 1 site📅 Started May 2023View details ↗
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
Study of MP0533 in Patients Acute Myeloid Leukemia or Myelodysplastic Syndrome
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
RecruitingNCT05046444 ↗
Solving Riddles Through Sequencing
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
👨⚕️ John M Salsman, PhD, ECOG-ACRIN Cancer Research Group📍 347 sites📅 Started Nov 2021View details ↗
RecruitingNCT05011045 ↗
Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
RecruitingNCT04466059 ↗
Better Leukemia Diagnostics Through AI (BELUGA)
👨⚕️ Wolfgang Kern, Prof. Dr., MLL Munich Leukemia Laboratory📍 1 site📅 Started Jan 2020View details ↗
RecruitingNCT03555851 ↗
Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
👨⚕️ Aleksander Chojecki, MD, Wake Forest University Health Sciences📍 1 site📅 Started Jul 2018View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →